Wiedmann, Lea A; Cairns, John A; Nolte, Ellen; (2024) Evidence Quality and Health Technology Assessment Outcomes in Reappraisals of Drugs for Rare Diseases in Germany. Value in health, 27 (12). pp. 1662-1670. ISSN 1098-3015 DOI: https://doi.org/10.1016/j.jval.2024.07.012

Wiedmann, Lea; Blumenau, Jack; Carroll, Orlagh; Cairns, John; (2024) Using automated text classification to explore uncertainty in NICE appraisals for drugs for rare diseases. International journal of technology assessment in health care, 40 (1). e5-. ISSN 0266-4623 DOI: https://doi.org/10.1017/S0266462323002805

Wiedmann, Lea; Cairns, John; (2023) Review of economic modeling evidence from NICE appraisals of rare disease treatments for spinal muscular atrophy. Expert review of pharmacoeconomics & outcomes research, 23 (5). pp. 469-482. ISSN 1473-7167 DOI: https://doi.org/10.1080/14737167.2023.2193690

Wiedmann, Lea; Nolte, Ellen; Cairns, John; (2025) Evidence quality and uncertainties considered in appraisal documents of drugs for rare diseases in England and Germany: a data extraction protocol. BMJ Open, 15 (2). e089418-. ISSN 2044-6055 DOI: https://doi.org/10.1136/bmjopen-2024-089418